Your browser doesn't support javascript.
loading
Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumab.
Abbadessa, Gianmarco; Miele, Giuseppina; Cavalla, Paola; Valentino, Paola; Marfia, Girolama Alessandra; Vercellino, Marco; De Martino, Antonio; Simeon, Vittorio; Lavorgna, Luigi; Bonavita, Simona.
Afiliação
  • Abbadessa G; Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, Naples 80131, Italy. Electronic address: gianmarco.abbadessa@unicampania.it.
  • Miele G; Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, Naples 80131, Italy.
  • Cavalla P; Department of Neuroscience and Mental Health, City of Health and Science University Hospital of Turin, Turin 10147, Italy.
  • Valentino P; Institute of Neurology, University "Magna Graecia", Catanzaro 88100, Italy.
  • Marfia GA; Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, Rome 00133, Italy.
  • Vercellino M; Department of Neuroscience and Mental Health, City of Health and Science University Hospital of Turin, Turin 10147, Italy.
  • De Martino A; Institute of Neurology, University "Magna Graecia", Catanzaro 88100, Italy.
  • Simeon V; Section of Medical Statistics, Department of Mental Health and Public Medicine, University of Campania Luigi Vanvitelli, Naples 80138, Italy.
  • Lavorgna L; Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, Naples 80131, Italy.
  • Bonavita S; Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, Naples 80131, Italy.
J Neuroimmunol ; 378: 578072, 2023 05 15.
Article em En | MEDLINE | ID: mdl-36996621
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: J Neuroimmunol Ano de publicação: 2023 Tipo de documento: Article País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: J Neuroimmunol Ano de publicação: 2023 Tipo de documento: Article País de publicação: Holanda